LakeShore Biopharma Revenue

In the fiscal year ending March 31, 2025, LakeShore Biopharma had annual revenue of 614.96M CNY with 7.24% growth. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.

Revenue

614.96M CNY

Revenue Growth

-6.54%

P/S Ratio

0.03

Revenue / Employee

1.07M CNY

Employees

573

Market Cap

2.65M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	614.96M	41.54M	7.24%
Mar 31, 2024	573.42M	-113.78M	-16.56%
Mar 31, 2023	687.20M	184.25M	36.63%
Mar 31, 2022	502.95M	245.93M	95.69%
Mar 31, 2021	257.02M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LakeShore Biopharma News

22 days ago - LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders - PRNewsWire
5 weeks ago - LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders - PRNewsWire
4 months ago - LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction - PRNewsWire
5 months ago - LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting - PRNewsWire
6 months ago - LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq - PRNewsWire
6 months ago - LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee - PRNewsWire
6 months ago - LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee - PRNewsWire
6 months ago - LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company - PRNewsWire

More News